Article Information
History
- March 28, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Erin Kelly, BA1,#,
- Mihael Varosanec, MD1,#,
- Peter Kosa, PhD1,
- Mary Sandford, CRNP1,
- Vesna Prchkovska2,
- David Moreno-Dominguez2 and
- Bibiana Bielekova, MD1,*
- 1Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
- 2QMENTA, Boston, USA
- ↵*To whom correspondence should be addressed: Bibiana Bielekova, MD, Neuroimmunological Diseases Section (NDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Building 10, Room 5N248, 10 Center Drive, MSC1444, Bethesda, Maryland 20892, USA. (Bibi.Bielekova{at}nih.gov)
↵# These authors contributed equally and are listed in alphabetical order
Posted March 28, 2021.
Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patients
